Cancer Patients Have a Higher Risk of Thrombotic and Ischemic Events After Percutaneous Coronary Intervention is a research paper published in JACC: Cardiovascular Interventions (2021). On theSindex it has a DataRank of 0. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA233610
National Institutes of Health
Grant: 5R01CA233610-02
TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial
National Institutes of Health
FWCI
4.97
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry
Additional file 1 of Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry
Additional file 1 of Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
Additional file 1 of Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction